These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1327029)

  • 21. Growth inhibition of human nasopharyngeal carcinoma in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
    Guan E; Zhou TC; Wang JH; Huang PG; Tang WP; Zhao ML; Chen Y; Sun YX
    Int J Cell Cloning; 1989 Jul; 7(4):242-56. PubMed ID: 2768842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F; Wang AP; Yang SF
    Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo.
    Zia F; Jacobs S; Kull F; Cuttitta F; Mulshine JL; Moody TW
    J Cell Biochem Suppl; 1996; 24():269-75. PubMed ID: 8806109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines.
    Heidtmann HH; Salge U; Havemann K; Kirschke H; Wiederanders B
    Oncol Res; 1993; 5(10-11):441-51. PubMed ID: 8054705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo.
    Kurachi H; Morishige K; Amemiya K; Adachi H; Hirota K; Miyake A; Tanizawa O
    Cancer Res; 1991 Nov; 51(21):5956-9. PubMed ID: 1933859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.
    Hida T; Leyton J; Makheja AN; Ben-Av P; Hla T; Martinez A; Mulshine J; Malkani S; Chung P; Moody TW
    Anticancer Res; 1998; 18(2A):775-82. PubMed ID: 9615719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
    García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
    Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway.
    DeCicco KL; Tanaka T; Andreola F; De Luca LM
    Carcinogenesis; 2004 Oct; 25(10):1805-12. PubMed ID: 15205358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of monoclonal antibody anti-EGF receptor on human nasopharyngeal carcinoma cell and other tumor cells.
    Guan EN; Zhou TC; Wang JH; Chen Y; Sun YX; Huang PG; Tang WP; Zhao ML
    Sci China B; 1990 Nov; 33(11):1334-40. PubMed ID: 2095159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
    Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model.
    Su CC; Yang JS; Lu CC; Chiang JH; Wu CL; Lin JJ; Lai KC; Hsia TC; Lu HF; Fan MJ; Chung JG
    Phytother Res; 2010 Feb; 24(2):189-92. PubMed ID: 20077433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor effects by a synthetic chalcone compound is mediated by c-Myc-mediated reactive oxygen species production.
    Kim TH; Seo WD; Ryu HW; Seo HR; Jin YB; Lee M; Ji YH; Park KH; Lee YS
    Chem Biol Interact; 2010 Oct; 188(1):111-8. PubMed ID: 20620131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
    Moody TW; Leyton J; Garcia-Marin L; Jensen RT
    Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.